Published in Brain Res Bull on February 01, 1991
A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis (2009) 1.92
Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol (2005) 1.31
Effective deep brain stimulation suppresses low-frequency network oscillations in the basal ganglia by regularizing neural firing patterns. J Neurosci (2012) 1.12
Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease. Neural Regen Res (2016) 0.76
Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse (1995) 1.34
Distribution of the uncoupling protein 2 mRNA in the mouse brain. J Comp Neurol (1998) 1.03
Atypical neuroleptic-like behavioral effects of neurotensin. Brain Res Bull (1993) 0.93
Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology (1996) 0.93
Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother (1996) 0.93
Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology (1998) 0.92
Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res (1997) 0.88
In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain Res Bull (1991) 0.85
Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit. Curr Eye Res (1994) 0.80
Effects of experimentally induced ischemia on dopamine metabolism in rabbit retina. Invest Ophthalmol Vis Sci (1993) 0.79
Relationships between structure and duration of neurotensin's central action: emergence of long acting analogs. Neuropeptides (1984) 0.79
Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration. Cancer Res (1988) 0.79
Trends in antibiotic resistance of staphylococci over an eight-year period: differences in the emergence of resistance between coagulase positive and coagulase-negative staphylococci. Microb Drug Resist (1998) 0.79
Evidence for involvement of A1 adenosine receptors in neurotensin-induced hypothermia. Ann N Y Acad Sci (1992) 0.79
The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist. Neuropeptides (1985) 0.79
Neurobehavioral profile of neuropeptide Y. Brain Res Bull (1991) 0.78
Antiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats. Brain Res (1991) 0.77
[Changes in the B wave of cones and rods in diabetes mellitus induced by streptozotocin in rats]. Ophtalmologie (1991) 0.77
Effects of retinal dopamine depletion on the rabbit electroretinogram. Doc Ophthalmol (1987) 0.77
Selective effects of retinal dopamine depletion on partial ischemia-induced electroretinographic hyperresponses in rabbits. Doc Ophthalmol (1994) 0.76
Modulation of human chorionic gonadotrophin bioactivity during the first trimester of pregnancy. Hum Reprod (1998) 0.76
Structure-activity analysis of CGRP's neurobehavioral effects. Ann N Y Acad Sci (1992) 0.76
The availability heuristic with famous names: a replication. Percept Mot Skills (2001) 0.75
[Not Available]. Can Fam Physician (1976) 0.75
Mitoxantrone use in breast cancer patients with elevated bilirubin. Breast Cancer Res Treat (1989) 0.75
Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing. Pharmacol Biochem Behav (1991) 0.75
Multidimensional locus of control and attitudes toward mental illness. Percept Mot Skills (1994) 0.75
CCK4-induced panic in healthy subjects II: neurochemical correlates. Eur Neuropsychopharmacol (1999) 0.75
Posterior hypothalamic receptors involved in the cardiovascular changes elicited by electrical stimulation of the rostral ventrolateral medulla. Neuropharmacology (1991) 0.75
Dextromethorphan attenuates the effects of ischemia on rabbit electroretinographic oscillatory potentials. Doc Ophthalmol (1993) 0.75
Neurobehavioral evidence for kappa agonist activity of the morphinan derivative 14-beta-methyl 8-oxacyclorphan [BC (3016)]. Pharmacol Biochem Behav (1991) 0.75
Effects of calcitonin gene-related peptide on the rabbit electroretinogram. Neuropeptides (1993) 0.75
Rapid assay of human plasma carboxypeptidase N by high-performance liquid chromatographic separation of hippuryl-lysine and its product. J Chromatogr (1983) 0.75